Search results for: "Novo Nordisk" (167 records) Novo Nordisk appoints vp for regulatory affairs Novo Nordisk reports solid Q1 sales growth Danish biopharmaceuticals and diabetes care specialist Novo Nordisk increased sales by 18% to Euro 1.7bn in the first quarter of 2009, led by modern insulins and NovoSeven.... Novo Nordisk puts US$400m into China insulin plant Novo Nordisk is to invest US400m (Euro 310m) in a new insulin production facility in China. Novo Nordisk acquires IP rights from Neose Technologies Novo Nordisk in Denmark, has signed an agreement to acquire intellectual property rights from Neose Technologies Inc. related to Neose\'s proprietary GlycoPEGylation technology. Novo Nordisk launches next generation prefilled insulin pen Novo Nordisk has launched a next generation of the FlexPen insulin injection device, incorporating new features providing improved safety, convenience and ease of use. Novo Nordisk files for regulatory approval of liraglutide in both the US and Europe Novo Nordisk has filed a New Drug Application (NDA) in the US and a marketing authorisation application in Europe for liraglutide, a once-daily human GLP-1 analogue, for the... Novo Nordisk donation aids efforts to combat neglected diseases Novo Nordisk has entered into a scientific collaboration that will benefit both Chinese pharmaceutical development and World Health Organization (WHO) efforts to combat... Sapphire Therapeutics licenses Ghrelin antagonist programme from Novo Nordisk New Jersey-based Sapphire Therapeutics, a private biopharmaceutical company that develops medicines acting on the ghrelin receptor for metabolic and oncologic diseases, has... Millipore and Novo Nordisk expand human insulin supply agreement US-based Millipore Corporation is expanding its agreement with Novo Nordisk to provide the biopharmaceutical market with recombinant human insulin, a key cell culture... Novo Nordisk expands manufacturing facility in US Novo Nordisk has opened its US$100m, 200,000 ft2 expanded facility in Clayton, North Carolina, to meet the country\'s increasing demand for FlexPen prefilled insulin pen. Novo Nordisk opens new pilot plant in Hillerod, Denmark A new pilot plant for the development and production of new biopharmaceuticals based on proteins cultured in mammalian cells, has been opened by Novo Nordisk. Novo Nordisk signs partnership agreement on CO2 reduction As part of its commitment to reducing its energy consumption and CO2 emissions, Danish healthcare company Novo Nordisk has signed a partnership agreement with Danish energy... Novo Nordisk inaugurates Latin America's largest insulin plant in Brazil Novo Nordisk has inaugurated a major expansion of its production facilities in Montes Claros, Brazil. The new plant, which is the largest manufacturing facility of Novo Nordisk... Sustainability Al Gore visits Novo Nordisk Former US Vice President Al Gore, has visited the Novo Nordisk headquarters in Bagsvaerd outside Copenhagen to learn of the company\'s work to address the climate change... Novo Nordisk and the Chinese Academy of Sciences establish research foundation Novo Nordisk and the Chinese Academy of Science (CAS) have signed an agreement that establishes a joint research foundation in China. Novo Nordisk divests of Dako Denmark-based provider of systems for cancer diagnostics, Dako, is divesting of its subsidiary Dako Denmark to the private equity fund EQT V. Previous1…56789 (current)1011Next